Net gamma exposure for Prime Medicine Inc (PRME) options was positive at the Nov 4, 2026 close, about $93.2K per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for PRME, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for PRME, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for PRME, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
PRME Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is PRME gamma exposure positive or negative?
Prime Medicine net gamma exposure was positive on Nov 4, 2026, at $93.2K. It has been positive on 20 of the last 20 trading days.
How has PRME gamma exposure changed recently?
Prime Medicine net gamma exposure went from $30.56K on Oct 7, 2026 to $93.2K on Nov 4, 2026. See the PRME gamma exposure history for a longer view.
What is Prime Medicine Inc?
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene...